BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 17978312)

  • 1. Aberrantly glycosylated IgA1 in glomerular immune deposits of IgA nephropathy.
    Giannakakis K; Feriozzi S; Perez M; Faraggiana T; Muda AO
    J Am Soc Nephrol; 2007 Dec; 18(12):3139-46. PubMed ID: 17978312
    [No Abstract]   [Full Text] [Related]  

  • 2. Differential glycosylation of polymeric and monomeric IgA: a possible role in glomerular inflammation in IgA nephropathy.
    Oortwijn BD; Roos A; Royle L; van Gijlswijk-Janssen DJ; Faber-Krol MC; Eijgenraam JW; Dwek RA; Daha MR; Rudd PM; van Kooten C
    J Am Soc Nephrol; 2006 Dec; 17(12):3529-39. PubMed ID: 17050773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pathogenic role of IgA1 O-linked glycosylation in the pathogenesis of IgA nephropathy.
    Barratt J; Smith AC; Feehally J
    Nephrology (Carlton); 2007 Jun; 12(3):275-84. PubMed ID: 17498123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical characterization of glomerular IgA deposits in IgA nephropathy.
    Suzuki S; Kobayashi H; Sato H; Arakawa M
    Clin Nephrol; 1990 Feb; 33(2):66-71. PubMed ID: 2107051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [IgA1 aberrant glycosylation in the pathogenesis of IgA nephropathy: an overivew].
    Xie L; Wang L; Huang J; Fan J
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2010 Feb; 27(1):227-30. PubMed ID: 20337060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Mesangial proliferative glomerulonephritis].
    Yamada A
    Nihon Rinsho; 2004 Oct; 62(10):1842-6. PubMed ID: 15500128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IgA nephropathy and aberrant glycosylation of tonsillar, serum and glomerular IgA1.
    Hiki Y; Ito A; Yamamoto Y; Yamamoto K; Iwase H
    Adv Otorhinolaryngol; 2011; 72():68-70. PubMed ID: 21865693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different glycosylation profile of serum IgA1 in IgA nephropathy according to the glomerular basement membrane thickness: normal versus thin.
    Linossier MT; Palle S; Berthoux F
    Am J Kidney Dis; 2003 Mar; 41(3):558-64. PubMed ID: 12612978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant Glycosylation of the IgA1 Molecule in IgA Nephropathy.
    Novak J; Barratt J; Julian BA; Renfrow MB
    Semin Nephrol; 2018 Sep; 38(5):461-476. PubMed ID: 30177018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mass spectrometry proves under-O-glycosylation of glomerular IgA1 in IgA nephropathy.
    Hiki Y; Odani H; Takahashi M; Yasuda Y; Nishimoto A; Iwase H; Shinzato T; Kobayashi Y; Maeda K
    Kidney Int; 2001 Mar; 59(3):1077-85. PubMed ID: 11231363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunoglobulin A (IgA) and its cellular receptors: Recent advances and new pathogenetical hypothesis].
    Amore A; Monteiro R; Coppo R
    G Ital Nefrol; 2006; 23(3):313-22. PubMed ID: 16868911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycosylation profile of differently charged IgA1 and their binding characteristics to cultured mesangial cells in IgA nephropathy.
    Leung JC; Chan LY; Tang SC; Tam PC; Fenn J; Lai KN
    Nephron Exp Nephrol; 2007; 107(3):e107-18. PubMed ID: 17957128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histology and immunohistology of IgA nephropathy.
    Haas M
    J Nephrol; 2005; 18(6):676-80. PubMed ID: 16358224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant glycosylation in IgA nephropathy (IgAN).
    Coppo R; Amore A
    Kidney Int; 2004 May; 65(5):1544-7. PubMed ID: 15086888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methodological approaches to the analysis of IgA1 O-glycosylation in IgA nephropathy.
    Allen AC
    J Nephrol; 1999; 12(2):76-84. PubMed ID: 10378662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IgA glycosylation and immune complex formation in IgAN.
    Suzuki H; Novak J
    Semin Immunopathol; 2021 Oct; 43(5):669-678. PubMed ID: 34570260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. O-glycosylation of serum IgD in IgA nephropathy.
    Smith AC; de Wolff JF; Molyneux K; Feehally J; Barratt J
    J Am Soc Nephrol; 2006 Apr; 17(4):1192-9. PubMed ID: 16510764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defining the spectrum of immunoglobulin A-dominant/codominant glomerular deposition in diabetic nephropathy.
    Cossey LN; Messias N; Messias E; Walker PD; Silva FG
    Hum Pathol; 2014 Nov; 45(11):2294-301. PubMed ID: 25239033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Engagement of transferrin receptor by polymeric IgA1: evidence for a positive feedback loop involving increased receptor expression and mesangial cell proliferation in IgA nephropathy.
    Moura IC; Arcos-Fajardo M; Gdoura A; Leroy V; Sadaka C; Mahlaoui N; Lepelletier Y; Vrtovsnik F; Haddad E; Benhamou M; Monteiro RC
    J Am Soc Nephrol; 2005 Sep; 16(9):2667-76. PubMed ID: 15987753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progress in the pathogenesis of IgA nephropathy.
    Julian BA; Tomana M; Novak J; Mestecky J
    Adv Nephrol Necker Hosp; 1999; 29():53-72. PubMed ID: 10561737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.